Braidwell »

Acadia Healthcare shares owned by Braidwell

Quarter-by-quarter ownership of Acadia Healthcare (ACHC) shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Acadia Healthcare

Tip: Access up to 7 years of quarterly data

All positions including Acadia Healthcare held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acadia Healthcare by Braidwell

Quarter filed Position value Share count Share price at filing
2026-03-31 $15M 646k 23.39

More positions owned by Braidwell

Caris Life Sciences (CAI)
Guardant Health Debt 1.250% 2/1 (Principal)
Repligen Corp Note 1.000%12/1 (Principal)
Neogenomics Note 0.250% 1/1 (Principal)
Neurocrine Biosciences (NBIX)
Glaukos (GKOS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Xenon Pharmaceuticals (XENE)
Dianthus Therapeutics (DNTH)
Edgewise Therapeutics (EWTX)
Irhythm Technologies (IRTC)
Nuvalent Inc-a (NUVL)
Kodiak Sciences (KOD)
Cg Oncology (CGON)
Alphatec Hldgs Note 0.750% 3/1 (Principal)

View all positions for Braidwell

Top funds holding Acadia Healthcare

Wellington Management Company
BlackRock
Vanguard Group
FMR
Khrom Capital Management
Vanguard Portfolio Management
Deerfield Management Company
DME Capital Management
Morgan Stanley
Abrams Bison Investments
Vanguard Capital Management
Carronade Capital Management
Leucadia National Corporation
State Street Corporation
Citadel Advisors

View all funds holding Acadia Healthcare